Making speech-based health analysis robust in the real world

Symptonic is a research initiative at Aalto University dedicated to enabling robust speech-based health analysis in variable remote environments.Speech carries significant health information, but speech-based biomarkers are often sensitive to environmental factors. Recordings vary by device, background noise, and compression, making results unreliable and limiting clinical adoption.Symptonic addresses this challenge.

• Interested? Get in touch!

Robust and uncertainty-aware speech biomarkers for real-world use

Our platform analyses how environmental factors affect speech-based biomarkers, helping improve robustness and quantify uncertainty. This can benefit the entire speech-based health technology sector, including researchers, medical device developers, digital health companies, and clinical partners seeking to deploy reliable biomarkers outside controlled laboratory settings.

Vision: Speech as a gateway to proactive care

We’re building a speech-based platform to enable more robust early detection and continuous monitoring for a wide range of health conditions, including:• Neurological disorders – such as Parkinson’s and Alzheimer’s• Cardiovascular conditions – including heart failure• Mental health challenges – like depression and anxiety• Respiratory diseases – including asthma and COVID-19By turning everyday speech into clinically meaningful data, we aim to make health monitoring seamless, scalable, and accessible – using the device already in your hand.

Join us in shaping the future of healthcare

We are actively seeking collaborators for pilot projects to validate and enhance our technology.If you are an investor, healthcare provider, research institution, or technology company interested in pioneering speech-based diagnostics, we invite you to connect with us.

• Interested? Get in touch!